Literature DB >> 2865550

Nebulised ribavirin for adenovirus pneumonia.

R M Buchdahl, P Taylor, J D Warner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2865550     DOI： 10.1016/s0140-6736(85)90941-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Economic and long-term benefits of ribavirin therapy on respiratory syncytial virus infection.

Authors:  N J Snell
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Adenovirus infection in families.

Authors:  O Ruuskanen; J Mertsola; O Meurman
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

3.  Treatment of adenoviral pneumonitis with intravenous ribavirin and immunoglobulin.

Authors:  I Sabroe; J McHale; D R Tait; W A Lynn; K N Ward; S Shaunak
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

4.  Pentamidine aerosol in prophylaxis and treatment of murine Pneumocystis carinii pneumonia.

Authors:  P M Girard; M Brun-Pascaud; R Farinotti; L Tamisier; S Kernbaum
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

Review 5.  Antiviral chemotherapy and prophylaxis of viral respiratory disease.

Authors:  S J Sperber; F G Hayden
Journal:  Clin Lab Med       Date:  1987-12       Impact factor: 1.935
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.